Relmada Therapeutics shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Relmada Therapeutics (RLMD) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Relmada Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Relmada Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Relmada Therapeutics by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $385k | 56k | 6.92 |
| 2022-09-30 | $522k | 14k | 37.04 |
| 2022-06-30 | $268k | 14k | 18.99 |
| 2022-03-31 | $380k | 14k | 26.99 |
| 2021-12-31 | $152k | 6.8k | 22.53 |
| 2021-09-30 | $177k | 6.8k | 26.21 |
| 2021-06-30 | $216k | 6.8k | 31.98 |
| 2021-03-31 | $238k | 6.8k | 35.21 |
| 2020-12-31 | $217k | 6.8k | 32.07 |
| 2020-09-30 | $254k | 6.8k | 37.61 |
| 2020-06-30 | $302k | 6.8k | 44.75 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors